scholarly journals Nonmedical Use of Xtampza® ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment: Real-World Data from the Addiction Severity Index-Multimedia Version (ASI-MV®)

2021 ◽  
Vol Volume 14 ◽  
pp. 1773-1783
Author(s):  
Jody L Green ◽  
Rebekkah S Robbins ◽  
Taryn Dailey-Govoni ◽  
Stephen F Butler
Keyword(s):  
Substance Abuse ◽  
Substance Abuse Treatment ◽  
Real World ◽  
Severity Index ◽  
Addiction Severity Index ◽  
Real World Data ◽  
World Data ◽  
Addiction Severity ◽  
Nonmedical Use ◽  
Abuse Treatment

OxyContin® use and misuse in three populations: Substance abuse patients, pain patients, and criminal justice participants

2018 ◽  
Vol 4 (2) ◽  
pp. 73 ◽  
Author(s):  
Martha J. Wunsch, MD ◽  
Karen L. Cropsey, PsyD ◽  
Eleanor D. Campbell, MS ◽  
Janet S. Knisely, PhD
Keyword(s):  
Substance Abuse ◽  
Criminal Justice ◽  
Prescription Medication ◽  
Severity Index ◽  
Addiction Severity Index ◽  
Pain Patient ◽  
Addiction Severity ◽  
Dsm Iv ◽  
Medical Histories ◽  
Rural Appalachia

Objective: This study was designed to describe and compare individuals in rural Appalachia prescribed, abusing or diverting OxyContin® a region with high rates of prescription medication abuse and misuse.Setting and Participants: Fifty subjects treated for OxyContin®abuse, 34 subjects prescribed OxyContin®for pain and 50 subjects incarcerated due to OxyContin®-related charges from rural Appalachia.Interventions: The Addiction Severity Index, DSM-IV Checklist, and an investigator developed questionnaire were administered to all three groups.Results: All three groups included individuals prescribed OxyContin® for pain and demographic variables and psychiatric/medical histories failed to discriminate between the pain and substance abuse (SA) subjects. SA and criminal justice subjects were significantly more likely to have a current DSM-IV diagnosis of psychoactive abuse/dependence and more likely to be younger and unmarried.Conclusion: This study found that these groups are not distinct and in depth evaluations, including a detailed SA history, are needed to identify the pain patient at risk for abuse and/or diversion of prescribed opioids.

Addiction severity assessment tool: Development of a self-report measure for clients in substance abuse treatment

2005 ◽  
Vol 80 (3) ◽  
pp. 349-360 ◽  
Author(s):  
Stephen F. Butler ◽  
Simon H. Budman ◽  
Michael D. McGee ◽  
Michael Sean Davis ◽  
Rebecca Cornelli ◽  
...  
Keyword(s):  
Substance Abuse ◽  
Substance Abuse Treatment ◽  
Assessment Tool ◽  
Self Report ◽  
Severity Assessment ◽  
Tool Development ◽  
Addiction Severity ◽  
Abuse Treatment ◽  
Report Measure

Nonmedical Use of Prescription ADHD Stimulant Medications Among Adults in a Substance Abuse Treatment Population

2013 ◽  
Vol 19 (4) ◽  
pp. 275-283 ◽  
Author(s):  
Theresa A. Cassidy ◽  
Emily C. McNaughton ◽  
Sajan Varughese ◽  
Leo Russo ◽  
Mirella Zulueta ◽  
...  
Keyword(s):  
Substance Abuse ◽  
Substance Abuse Treatment ◽  
Nonmedical Use ◽  
Stimulant Medications ◽  
Abuse Treatment ◽  
Treatment Population

Client Satisfaction with Drug Abuse Day Treatment versus Residential Care

1997 ◽  
Vol 27 (2) ◽  
pp. 367-377 ◽  
Author(s):  
Monica Chan ◽  
James L. Sorensen ◽  
Joseph Guydish ◽  
Barbara Tajima ◽  
Alfonso Acampora
Keyword(s):  
Drug Abuse ◽  
Residential Treatment ◽  
Client Satisfaction ◽  
Day Treatment ◽  
Severity Index ◽  
Addiction Severity Index ◽  
Addiction Severity ◽  
Support Measure ◽  
Symptom Check List ◽  
Abuse Treatment

We compared overall treatment satisfaction and helpfulness of treatment components for 216 clients randomly assigned to day versus residential treatment. Baseline interviews were conducted near admission using the Addiction Severity Index, Beck Depression Inventory, Symptom Check-list-90-R, and a social support measure. Follow-up interviews occurred 6 months later with these instruments plus a client satisfaction measure. Clients in both day and residential treatment were highly satisfied with overall services and most treatment components. Satisfaction scores were high and did not differ between modalities; however, mental health services were less helpful to day treatment clients, and more day treatment clients indicated not receiving certain treatment components. Client satisfaction correlated with treatment retention and several baseline and 6-month severity outcomes. These findings indicate day treatment may be as satisfying to clients as residential treatment, and give credence to the idea that client satisfaction assessment should be routine in outcome evaluations of drug abuse treatment.

Sign in / Sign up

Export Citation Format

Share Document